FindTrial
Sign In

Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurity

Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurity - Clinical study about the retinopathy of prematurity

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025361
Enrollment
20
Registered
2017-01-10
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinopathy of prematurity

Interventions

Ocular administration of anti-VEGF antibody

Sponsors

Nara Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aggressive progresssive retinopathy of prematurity

Exclusion criteria

Exclusion criteria: Case of Retinal Detachment

Design outcomes

Primary

MeasureTime frame
Stage and zone of the retinopathy of prematurity—

Secondary

MeasureTime frame
Birth week Birth weight Visual acuity Intraocular pressure Incidence of retinal detachment Counts of treatment Retinal photocoagulation—

Countries

Japan

Contacts

Public ContactTomo Nishi

Nara Medical University Department of ophthalmology

tomon@naramed-u.ac.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026